imatinib mesylate has been researched along with Marfan Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiménez, SA; Rosenbloom, J | 1 |
1 other study(ies) available for imatinib mesylate and Marfan Syndrome
Article | Year |
---|---|
Angiotensin II blockade in Marfan's syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzamides; Fibrillins; Humans; Imatinib Mesylate; Losartan; Marfan Syndrome; Microfilament Proteins; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Transforming Growth Factor beta | 2008 |